Modern genetic approaches are powerful in providing access to diverse cell types in the brain and facilitating the study of their function. Here, we report a large set of driver and reporter transgenic mouse lines, including 23 new driver lines targeting a variety of cortical and subcortical cell populations and 26 new reporter lines expressing an array of molecular tools. In particular, we describe the TIGRE2.0 transgenic platform and introduce Cre-dependent reporter lines that enable optical physiology, optogenetics, and sparse labeling of genetically defined cell populations. TIGRE2.0 reporters broke the barrier in transgene expression level of single-copy targetedinsertion transgenesis in a wide range of neuronal types, along with additional advantage of a simplified breeding strategy compared to our first-generation TIGRE lines. These novel transgenic lines greatly expand the repertoire of high-precision genetic tools available to effectively identify, monitor, and manipulate distinct cell types in the mouse brain.
INTRODUCTION
The nervous system is composed of myriad cell types in a highly organized and coordinated manner to produce function (Zeng and Sanes, 2017) . Neuronal cell types have diverse molecular, morphological, and physiological properties and are interconnected to form multiple levels of neural circuits that generate behavior. Efforts have been underway to systematically profile these properties at the single-cell level and develop celltype classification schemes; to build connectomes at micro-, meso-, and macroscopic levels; and to probe neuronal activities in behaving animals. All these levels of investigation are necessary to obtain fundamental understanding of how the nervous system works. And central to all these investigations is our ability to gain access to individual cell types, to perform circuit dissection, and to connect information gathered at gene, cell, and network levels (Huang and Zeng, 2013; Luo et al., 2008) .
Cell-type-specific genetic tools constitute a powerful approach for the study of brain function via targeted expression of a variety of molecular sensors and probes in different cell types. In the mouse, the Cre/Lox system has been widely applied with a large number of Cre driver transgenic mouse lines now available. This, combined with other recombinases and transcriptional regulation systems (Dymecki et al., 2010; Huang and Zeng, 2013; Madisen et al., 2015) , has allowed more refined and flexible control of specific cell populations. Recent advances in single-cell transcriptomics have yielded novel celltype-specific marker genes, and this, coupled with the development of new and better genetically encoded molecular sensors and probes, continues to fuel the genetic-tool-generation pipeline. Overall, the creation of new cell-type-specific genetic tools holds tremendous promise in enabling better labeling, monitoring, and manipulation of these neural circuit components and, ultimately, detailed mechanistic insight on brain function. At the same time, the demand for genetic tools with better specificity and performance still far exceeds their current availability, and much work is needed to convert promise into reality.
For expressing genetic tools, in addition to the commonly used Rosa26 locus, we previously explored another permissive genomic locus, TIGRE, to establish a series of intersectional reporter lines controlled by Cre and a tetracycline-regulated transcriptional transactivator, tTA (Madisen et al., 2015; Zeng et al., 2008) . We found that these TIGRE-based lines afforded substantially higher reporter and effector gene expression compared to the Rosa26-based lines, likely due to tTA/TRE-mediated transcriptional amplification. This is a critical improvement as sufficiently high-level expression of many molecular tools, such as fluorescent proteins, calcium indicators, and channelrhodopsins, is needed to allow full-extent visualization of fine neuronal structures and effective reporting or manipulation of neuronal activities in vivo in a minimally invasive fashion.
In this paper, we report a large and diverse set of new celltype-specific transgenic mouse lines, including 23 new driver lines (15 Cre and 8 Flp lines) and 26 new reporter lines. The reporter lines express a variety of molecular tools that will enable a wide range of applications. In particular, we have developed a new transgene design in the TIGRE locus, in which a Credependent tTA-expressing transgene cassette was co-integrated into TIGRE along with the Cre and tTA-dependent reporter gene cassette. This approach converts the TIGRE reporter lines into simple Cre-reporters while retaining the tTA-mediated transcriptional amplification. We name these second-generation TIGRE lines TIGRE2.0 and our previous Cre-and tTA-dependent TIGRE lines TIGRE1.0. TIGRE2.0 lines simplify breeding strategies and expand the repertoire of cell types with strong reporter gene expression to nearly all the cell types we have examined. Single-cell transcriptomics analysis shows that TIGRE2.0 reporters have reached a transgene expression level comparable to that of strong promoter-driven recombinant adeno-associated virus (AAV) vectors, breaking a significant barrier in single-copy targeted-insertion transgenesis. Importantly, we demonstrate superior functionality of many new transgenic lines and also disclose side effects observed in animals with extremely high-level and widespread transgene expression in some circumstances. Experiences gained and lessons learned in the extensive study reported here will be invaluable for the utilization and further development of optimal genetic targeting strategies.
RESULTS
The transgenic mouse program at the Allen Institute for Brain Science has generated transgenic mouse lines for cell-type-specific labeling and manipulation for the past 10 years (Harris et al., 2014; Madisen et al., 2010 Madisen et al., , 2012 Madisen et al., , 2015 . A total of 56 driver lines and 54 reporter lines have been generated. Transgene expression patterns in the entire mouse brain for the majority of these lines have been systematically characterized using our RNA in situ hybridization (ISH) pipeline, and all the data are available at the brain-map.org portal (http://connectivity.brain-map. org/transgenic; http://www.alleninstitute.org/what-we-do/brainscience/research/products-tools/). To provide a comprehensive and centralized overview, all transgenic lines generated in the Allen Institute are summarized in Table S1 for driver lines and Table  S2 for reporter lines. Most of these lines have been deposited to the Jackson Laboratory, and they have been widely utilized in the broad research community. Out of these 110 lines, 33 driver and 28 reporter lines have been described in previous publications, whereas the remaining 23 driver and 26 reporter lines are formally reported for the first time in this paper.
New Cre and Flp Driver Lines Targeting a Variety of Cell Populations
The 23 new driver lines (Table S1 ) were created by inserting Cre or FlpO into the C terminus of an endogenous gene via homologous recombination, using either conventional or CRISPR/Cas9-mediated approaches, with driver gene expression mediated by either an internal ribosome entry site (IRES, variant IRES2 in particular) or a 2A peptide (T2A or P2A) sequence. Out of these, 15 lines express variants of Cre, including Cre itself, tamoxifeninducible CreERT2, trimethoprim (TMP)-inducible dCre (DHFRCre) or dgCre (DHFR-GFP-Cre) (Sando et al., 2013) , and 8 lines express FlpO or its TMP-inducible version dgFlpO (DHFR-GFP-FlpO).
Target genes chosen for making Cre and FlpO driver lines to supplement existing lines include cortical layer-selective genes that label mainly excitatory neurons (e.g., Calb1, Htr1a, Npr3, Plxnd1, Rasgrf2, and Rorb) , neuropeptide and receptor genes (e.g., Cart, Esr2, Npy, Oxtr, Pdyn, Penk, Tacr1, and Vipr2) , genes targeting specific cell populations (e.g., Fezf1 for ventromedial hypothalamus, Gnb4 for claustrum, and Tnnt1 for thalamus), and pan-GABAergic (Slc32a1, also known as Vgat) or glutamatergic (Slc17a6, also known as Vglut2, and Slc17a8, also known as Vglut3) genes. Expression patterns of the driver genes and the tdTomato reporter gene were examined by ISH ( Figure 1A ).
The expression patterns of all driver transgenes largely recapitulate the adult (P56) expression patterns of their endogenous target genes. On the other hand, the expression patterns of Cre and Flp reporters are often more widespread, likely due to the cumulative recombination from transient expression of the driver genes in developmental or adult stages. An observed trend is that IRES-mediated drivers tend to drive more faithful expression of the reporters, whereas 2A-mediated drivers often lead to more widespread reporter expression. Also, dCre and dgCre can mediate efficient recombination as do Cre and FlpO, whereas CreERT2 and dgFlpO tend to have less efficient recombination as indicated by the sparser activation of the reporters.
We examined the co-expression of tdTomato reporter with a pan-GABAergic marker Gad1 by double fluorescence in situ hybridization (dFISH) in several cortical layer-selective driver lines (A) Selected images from ISH characterization of all new driver lines using either tdTomato reporter probe or Cre probe as indicated on each panel. Full ISH datasets are viewable at http://connectivity.brain-map.org/transgenic. Ai14 was used to examine all Cre lines, and Ai65F was used for all FlpO lines. The only exception is Tnnt1-IRES2-CreERT2, which was crossed to a new TIGRE2.0 reporter Ai140, and TissueCyte imaging shows extremely sparse GFP labeling of thalamic neurons (after 1-day tamoxifen induction at P10). For region acronyms, see STAR Methods. (B) Examination of excitatory and inhibitory neuronal labeling in example cortical layer-selective driver lines. Representative images of dFISH in VISp, using tdTomato reporter (green) and pan-GABAergic marker Gad1 (red) probes, are shown. The extent of reporter expression in inhibitory neurons varied from none (Plxnd1-IRES2-dgFlpO, Rorb-P2A-FlpO) to a few cells (Rasgrf2-T2A-dgFlpO) to many cells (Calb1-IRES2-Cre). See also Tables S1 and S3 . (legend continued on next page) and found that they indeed label predominantly excitatory neurons in a layer-specific manner, with some lines also labeling some inhibitory interneuron populations ( Figure 1B ). We also characterized the eight driver lines expressing the DHFRdomain-containing dCre, dgCre, or dgFlpO. Recombinases fused to the destabilizing DHFR domain (Sando et al., 2013) , which can be stabilized by the administration of an antibiotic TMP, constitute a safer alternative inducible recombinase system compared to CreERT2, whose requirement of tamoxifen dosing can lead to undesired side effects. We examined the recombination patterns of DHFR-containing driver lines in the adult stage without or with TMP induction (Table S3 ) and found substantial variability in baseline and induced states across different lines, suggesting that such characterization is critical for the proper use of these types of lines.
New Rosa26 and TIGRE1.0 Reporter Lines We first summarize a set of Rosa26-based Cre reporter lines we generated but have not formally reported previously ( Figure S1A ; Table S2 ). These include Ai31 (with synapse-localized Synaptophysin-EmGFP), Ai34 (with synapse-localized SynaptophysintdTomato), Ai40 (with archeorhodopsin ArchT-GFP), Ai47 (with three tandemly linked GFP molecules EmGFP-T2A-TagGFP2-P2A-hrGFP), Ai75 (with nuclear-localized nls-tdTomato), Ai80 (a Cre and Flp double reporter with channelrhodopsin CatCh) (Kleinlogel et al., 2011) , Ai86 (with voltage sensor ArcLight) (Jin et al., 2012) , and Ai110 (a Cre and Flp dual reporter expressing nuclear-localized nls-mNeonGreen when only Cre is present and nls-tdTomato when both Cre and Flp are present). All of these lines display appropriate reporter gene expression when crossed to various Cre lines (Figures S1B-S1E).
We also generated a knock-in Chrm2-tdT line, in which tdTomato was fused to the C terminus of the endogenous muscarinic acetylcholine receptor 2 (Chrm2) gene ( Figure S1A ). Immunostaining of CHRM2 can be used to delineate cytoarchitectonic boundaries of various cortical areas (such as primary visual and somatosensory cortices) (Ji et al., 2015) . We find that such delineation is preserved by native fluorescence of the CHRM2-tdTomato fusion in Chrm2-tdT mice ( Figure S1F) ; thus, this line can be used to visualize cortical area boundaries in vivo.
We created a Flp-reporter line, Ai65F, and a Dre-reporter line, Ai66R ( Figure S1A ), by performing EIIa-Cre-mediated germline deletion of the Lox-STOP-Lox (LSL) cassette from our previously reported, Rosa26-based double reporter line of Cre and Flp, Ai65, and of Cre and Dre, Ai66, respectively (Madisen et al., 2015) . Similarly, we created a tTA-reporter line Ai63 ( Figure S1A ) from the TIGRE-based Cre and tTA double reporter line Ai62. Expected specificity for their respective driver lines was observed ( Figures 1A and S1G ).
We generated several additional TIGRE1.0 lines (Figure 2A ) expressing new tools. These include Ai90 (with channelrhodopsin Chronos-GFP) (Klapoetke et al., 2014) , Ai133 (with an electron microscopy tag ssAPEX2tm) (Lam et al., 2015) , Ai134 (with channelrhodopsin ChR2(H134R)-YFP), and Ai136 (with channelrhodopsin ReaChR-YFP) (Lin et al., 2013) (Figure 2B ). In the required triple-transgenic setting (Cre x tTA x reporter), we found that the use of a moderately expressing tTA line, ROSA26-ZtTA (Li et al., 2010) , led to good opsin expression when combining Ai90, Ai134, or Ai136 with cortical layer 4-or 6-specific Cre lines (Scnn1a-Tg3-Cre or Ntsr1-Cre_GN220) ( Figure 2C ). On the other hand, the use of a strong tTA driver, Camk2a-tTA, led to fluorescent aggregates in cells and/or aberrant morphology of labeled cells (data not shown), indicating adverse effects of overexpression of these opsin proteins.
Ai133 expresses ascorbate peroxidase APEX2 (Lam et al., 2015) tagged with a T cell CD2 antigen signal sequence (ss) and a transmembrane targeting sequence (tm), which we found to be compatible with transcardial perfusion and fixation with glutaraldehyde-a necessary step toward obtaining ultrastructure preservation for electron microscopy (EM). Incubation of coronal slices from Scnn1a-Tg3-Cre;Camk2a-tTA;Ai133 animals with 3,3 0 -diaminobenzidine enhanced with nickel (DABNi) showed specific peroxidase activity in cortical layer 4 as expected ( Figure 2D ). Processing DAB-Ni stained tissue with a reduced osmium tetroxide (ROTO) protocol provided strong EM contrast and identification of APEX2-positive cell processes ( Figures 2E-2I ).
TIGRE2.0 Reporter Lines with Enhanced Expression
The TIGRE1.0 lines rely on two drivers for cell-type-specific and high-level transgene expression (Madisen et al., 2015) (Figure 2A ). This triple transgenic design is limited by the availability of only a few well-functioning tTA lines. We previously observed robust transgene expression in cortical excitatory neurons and a subset of cortical interneurons or subcortical neurons but poor expression in many other neuronal types. To overcome this problem and to simplify breeding, we investigated ways to incorporate tTA-mediated transcriptional amplification into the TIGRE locus itself along with the reporter transgene (see Figure S2 legend).
We co-inserted two complete transgene-expressing units, separated by tandem HS4 insulators to mitigate potential interference between the two units, into the same TIGRE locus ( Figure 3A ). The first unit contains TRE2 promoter-driven, LSLcontrolled reporter gene (e.g., GFP), and the second unit contains CAG promoter-driven, LSL-controlled tTA2 gene (or tdTomato-P2A-tTA2). We named this approach TIGRE2.0. In the presence of Cre, both STOP signals would be excised, (C) Robust Cre/tTA-dependent expression of opsins in cortical layer 6 and 4 neurons. (D) APEX2 activity revealed by DAB-Ni staining. Bright-field images reveal staining within somatic, dendritic, and axonal compartments of neurons located in several cortical regions, including layer 4 of VISp (enlarged image). (E-G) Electron micrographs show APEX2-dependent labeling of both pre-and post-synaptic terminals. Examples include synapses (arrowheads) between a labeled bouton (b) and an unlabeled spine (sp) (E) , between a labeled bouton and a labeled spine (F) , and between a labeled bouton and an unlabeled dendritic shaft (d) (G) . (H and I) Electron micrographs show APEX2-dependent labeling of fine, unmyelinated (H) or myelinated (I) axons (arrows). See also Table S2 and Figure S1 . thereby allowing CAG promoter to drive tTA2 expression, which would in turn activate the reporter gene expression. We developed two prototype TIGRE2.0 lines expressing GFP: Ai139(TIT2L-GFP-ICL-TPT) (stands for TIGRE-insulators-TRE2 promoter-LoxPStop1LoxP-GFP-insulators-CAG promoterLox2272Stop2Lox2272-tdTomato-P2A-tTA2) and Ai140(TIT2L-GFP-ICL-tTA2) ( Figures 3A and 3D ). To determine whether tTA2 expression from within the TIGRE locus is sufficient, we crossed these two lines to several Cre lines and examined GFP expression in a variety of cell types. In all cases, we observed strong native GFP fluorescence throughout cortical and subcortical areas (Figures 3B, 3D , and S2A), including Pvalb+ and Sst+ interneurons for which poor expression had been seen in TIGRE1.0 lines. Reporter expression could be reversibly suppressed by doxycycline ( Figure 3C ). We generated three TIGRE2.0 reporter lines expressing GCaMP6f or GCaMP6s: Ai148(TIT2L-GC6f-ICL-tTA2), Ai162 (TIT2L-GC6s-ICL-tTA2) and Ai163(TIT2L-GC6s-ICL-TPT) (Figure 3E) . To compare with Rosa26-based reporters, we generated triple transgenic mice containing both Ai14 and Ai148 along with one of five Cre lines. With cortical layer-specific Cre lines (Figure 3F) , we observed near-complete overlap between GCaMP6f+ and tdTomato+ cells. With the three cortical interneuron-specific Cre lines ( Figure 3G ), GCaMP6f and tdTomato were largely co-expressed, but we also detected cells expressing only tdTomato, indicating that the difficulty of achieving tTA-dependent expression in interneuron populations is not fully overcome. This is particularly the case for Pvalb+ interneurons, which had the lowest proportion of GCaMP6f+ cells relative to tdTomato+ cells. On the other hand, we observed robust GCaMP6s expression in many Pvalb+ cells when crossing Ai162 or Ai163 with Pvalb-IRES-Cre ( Figure 3G ). Quantification confirmed that GCaMP6s was expressed in a larger (in Ai162) or substantially larger (in Ai163) portion of Pvalb+ cells than GCaMP6f (in Ai148) ( Figures 3I and 3J) .
We investigated Ai148 GCaMP6f expression in subcortical neuromodulatory neurons by quantifying the fraction of cells expressing GCaMP6f driven by corresponding Cre lines in cholinergic, dopaminergic, noradrenergic, and serotoninergic neurons identified by immunohistochemistry (IHC) ( Figures 3H, 3I , S3A, and S3B). A large fraction of neuromodulatory neurons displayed strong native GCaMP6f fluorescence without IHC enhancement. This is a substantial improvement over previous generations of both Rosa26 and TIGRE1.0 GCaMP6 reporter lines, in which GCaMP6 fluorescence was virtually undetectable in neuromodulatory neurons, shown as an example in the cholinergic neurons ( Figures S3C and S3D ).
We generated two TIGRE2.0 lines expressing new opsins: Ai167(TIT2L-ChrimsonR-tdT-ICL-tTA2) and Ai168(TIT2L-oChIEF-P2A-tdT-ICL-tTA2) ( Figure 4A ). In Cux2+ cortical layer 2/3 neurons, strong membrane fluorescence for the ChrimsonR-tdTomato fusion protein was observed ( Figure 4B ). In this case, we also show that TIGRE2.0 lines can be combined with TIGRE1.0 lines to achieve dual expression of two reporter genes from a single Cre-dependent tTA2 expression unit, as seen in Cux2-CreERT2;Ai93;Ai167, in which both ChrimsonR-tdT (from Ai167) and GCaMP6f (from Ai93) were expressed in the same or different Cre+ cells. In Ai168, oChIEF, specifically oChIEF AC , was expressed singly and not fused to a fluorescent protein, so its expression was revealed by immunostaining using an antibody against the 2A peptide, and it coincided well with the tdTomato fluorescence ( Figure 4C ).
We generated two TIGRE2.0 lines expressing a voltage sensor ASAP2s: Ai169(TIT2L-ASAP2s-ICL-tTA2) and Ai170 (TIT2L-ASAP2s-Kv-ICL-tTA2), in which ASAP2s is tagged with a 65-amino-acid cytosolic segment of Kv2.1 to restrict protein localization to the soma and proximal dendrites (Baker et al., 2016; Lim et al., 2000; Wu et al., 2013) (Figure 4A ; Table S4 ). Both lines exhibit robust fluorescence with expected localizations-membrane-localized throughout neuronal processes for ASAP2s in Ai169 and soma-enriched for ASAP2s-Kv in Ai170 ( Figure 4D ). See also Figure S4 and Table S4 . To quantitatively evaluate transgene expression levels in TIGRE2.0 lines, we isolated individual cells from different mouse lines by fluorescence-activated cell sorting (FACS) and performed single-cell RNA sequencing using the SMART-Seq v4 method (Tasic et al., 2016) ( Figure 4E ). In all inhibitory and excitatory neuronal types examined, TRE2 promoter-driven reporter levels of GFP in Ai139, GCaMP6f in Ai148, and GCaMP6s in Ai162 or Ai163 were 40-to 400-fold higher than CAG promoter-driven tdTomato levels in Ai14 or Ai139. We also noted that tTA2 levels were significantly higher when expressed alone (in Ai148 and Ai162) than in the tdT-P2A-tTA2 configuration (in Ai139 and Ai163); however, this did not translate into higher TRE2-driven reporter levels, indicating a saturation had been reached. We further found that TIGRE2.0 reporter gene levels were comparable to the GFP expression level from excitatory or inhibitory neurons 3-5 weeks after infection with a very strong, Cre-dependent adeno-associated viral vector, AAV-pCAG-FLEX-EGFP-WPRE-pA ( Figure 4E ), suggesting that strong viral-like expression level has been achieved in TIGRE2.0 lines.
To assess the effect of high-level transgene expression, we examined transcriptome-wide changes by comparing the single-cell transcriptomes from the above Cre x TIGRE2.0 mice to those from matching classes of cells from Cre x Ai14 mice and found no substantial changes in global gene expression (Figure S4) . We also found that a group of immune-responsive genes were substantially upregulated in AAV-infected cells but not in TIGRE2.0 cells.
In Vivo Calcium Imaging In Cortical Neurons Using TIGRE2.0 GCaMP6 Reporters To evaluate the utility of TIGRE2.0 mice in studying cortical interneurons, in vivo two-photon (2P) calcium (Ca) imaging was conducted in triple transgenic mice containing Ai14 and Ai148 reporters and one of the Cre lines specific for Pvalb, Sst, or Vip interneurons. Co-expressing tdTomato with GCaMP6f facilitated the localization of and Ca imaging in those interneurons with low neural activity or fluorescence ( Figure 3G ).
2P Ca imaging was conducted in layer 2/3 (110-350 mm below the pia) through an implanted cranial window over the left primary visual cortex (VISp) in head-fixed, awake mice. Ca imaging with drifting gratings (Figures 5 and S5A-S5D) confirmed that Ai148/162/163 mice greatly improved the expression of GCaMP6 in interneurons with high specificity, compared to the absent or low expression in corresponding Ai93/Ai95 mice (Madisen et al., 2015) . Sst-IRES-Cre;Ai14;Ai148 mice showed large evoked fluorescence changes (DF/F) in response to drifting gratings and a great degree of variation of baseline and visually evoked fluorescence. Large responses were also seen in Vip-IRES-Cre;Ai14;Ai148 mice, and the behavioral state (running versus stationary) dependency was well evident. In Pvalb-IRES-Cre;Ai14;Ai148 mice, the number of GCaMP6f-expressing cells was small and Ca response was low. Thus, we also performed in vivo 2P Ca imaging in Pvalb-IRES-Cre;Ai162 and Pvalb-IRES-Cre;Ai163 mice, in which we observed much stronger spontaneous and visually evoked responses.
To quantify the improvement of Ai148 over Ai95, we compared the fluorescence responses of cells in Sst-IRES-Cre;Ai14;Ai148 mice (two mice, eight fields of view [FOVs] ) with those in Sst-IRES-Cre;Ai95 (two mice, six FOVs) ( Figure 5D ). To control for imaging noise, we calculated the mean maximum response of individual cells by taking the maximal DF/F response averaged within 1 s (0.5-1.5 s) post-stimulus onset during the entire recording episode. Compared with Ai95, the distribution of mean maximum responses in Ai148 showed a significant rightward shift (p < 0.001, Kolmogorov-Smirnov test). The average amplitude of Ai148 response was larger (72.45% ± 5.88% DF/F, mean ± SEM, same below) than that of Ai95 (18.93% ± 1.18%, p < 0.001, t test). The noise level (3.69% ± 0.15% DF/F) in Ai148 remained comparable with that in Ai95 (3.86% ± 0.11%, p = 0.37, t test). Thus, Ai148 had significantly increased signal/noise ratio by $4-fold (22.84 ± 1.96 versus 4.94 ± 0.31, p < 0.001, t test).
Strong fluorescence responses were also observed in GCaMP6s-expressing Ai163 and Ai162 lines. In Pvalb-IRESCre;Ai163 (three mice, 18 FOVs), for example, responses in Pvalb neurons were on average $5-fold (52.39% ± 1.05% DF/F) greater than those of Pvalb-IRES-Cre;Ai14;Ai148 (9.74% ± 1.10%, two mice, six FOVs; p < 0.001, t test) ( Figure 5E ). Although the baseline noise was higher (3.26% ± 0.05% versus 2.46% ± 0.07%, p < 0.001, t test) due to the high activity level of Pvalb neurons in vivo and increased sensitivity in Ai163, overall the signal-to-noise ratio significantly increased by $4-fold compared with Ai148 (17.42 ± 0.47 versus 4.48 ± 0.56, p < 0.001, t test, Figure 5E ).
To also assess the utility of Ai148 for imaging excitatory neurons, we crossed Ai148 with Cre-lines targeting deep cortical layers. Ntsr1-Cre_GN220;Ai148 mice expressed GCaMP6f strongly and specifically in layer 6 across the cortex ( Figure S5E ), while Ntsr1-Cre_GN220;Camk2a-tTA;Ai93 mice displayed less specificity, with strong expression in some layer 5 cells as well ( Figure S5F ). While imaging in VISp layer 6, both sets of mice showed strong visually evoked responses to drifting gratings (Figures S5E and S5F) . Comparison of the distribution of response amplitudes showed larger changes in fluorescence in Mouse lines examined are Scnn1a-Tg3-Cre;ROSA26-ZtTA;Ai90 (simplified as Scnn1a-Ai90 or Ai90, same below), Scnn1a-Tg3-Cre;ROSA26-ZtTA;Ai134, Scnn1a-Tg3-Cre;ROSA26-ZtTA;Ai136, Scnn1a-Tg3-Cre;Ai167, and Scnn1a-Tg3-Cre;Ai168. (A) Representative examples of light-evoked currents in response to 100 ms stimulation (indicated by gray shading). Traces are from individual neurons and are normalized to their peak current amplitude. (B) Average ± SD of peak current amplitude and data points for individual cells from each transgenic line. Ai90: 0.59 ± 0.36 nA; Ai134: 0.88 ± 0.36 nA; Ai136: 2.76 ± 1.34 nA; Ai167: 1.99 ± 0.50 nA; Ai168: 0.19 ± 0.18 nA. *p < 0.005 (n = 6-10 cells for each line).
Ai93, both when recording in layer 6 (Ntsr1-Cre_GN220 in Figure S5G averaged 25% ± 3% DF/F in Ai93, n = 183 cells, and 12% ± 1% in Ai148, n = 310 cells) and in layer 5 (Tlx3-Cre_PL56 in Figure S5H ; 20% ± 5% DF/F in Ai93, n = 281 cells, and 12% ± 1% in Ai148, n = 349 cells). However, many more GCaMP6f+ cells were detected with Ai148 overall in both excitatory populations, suggesting that this reporter may have detected more cells with no or low evoked activities.
Light-Response Properties of TIGRE1.0 and TIGRE2.0 Optogenetic Mice We characterized the light responses of the three new TIGRE1.0 lines and two new TIGRE2.0 lines expressing various channelrhodopsin variants in acute slices of VISp. Recordings were targeted to opsin-positive neurons in layer 4. We stimulated neurons from Ai90, Ai134, and Ai168 mice using a blue LED (470 nm). The reported photo-activation spectra of ReaChR and ChrimsonR are red shifted compared to ChR2 (Klapoetke et al., 2014; Lin et al., 2013) ; therefore, we utilized a red-orange LED (590 nm) to stimulate cells in Ai136 and Ai167 mice.
As observed in the initial description of each opsin, the photocurrents carried by these five variants demonstrate distinct kinetics ( Figure 6A ). Photocurrents from Chronos+ cells (Ai90) displayed the most rapid kinetics with a sub-millisecond time constant of activation ( Figure S6A ). By comparison, activation kinetics were slightly slower in oChIEF+ (Ai168), ChrimsonR+ (Ai167), and ChR2+ (Ai134) neurons and dramatically slower in ReaChR+ (Ai136) neurons. We also observed similar pattern in deactivation kinetics for these opsins ( Figure S6B ). Chronos and ChR2 photocurrents both displayed significant desensitization over the course of a 100 ms stimulus, while desensitization was significantly lower for oChIEF or ChrimsonR and absent in ReaChR ( Figure S6C ).
Ai167 exhibited large-amplitude ChrimsonR-mediated photocurrents ( Figure 6B : peak current amplitude = 1.99 ± 0.50 nA, n = 10). By contrast, Ai168 oChIEF-mediated photocurrents were an order of magnitude smaller. Among the three TIGRE1.0 lines tested, Ai136 peak current amplitudes were comparable to Ai167, while Ai134 and Ai90 were significantly smaller. To compare variability of opsin expression within transgenic lines, we measured the coefficient of variation (CV) of the peak current amplitudes between cells. Notably, Ai167 displayed the smallest CV (CV = 0.25; compared to CV = 0.62, 0.42, 0.48, and 0.93 for Ai90, Ai134, Ai136, and Ai168, respectively), suggesting that the Ai167 line provides robust and consistent opsin expression from cell to cell. We compared photosensitivity by measuring currents across a range of light intensities ( Figure 6C ). All five lines displayed strong sensitivity to light intensity with the greatest sensitivity seen in Ai167 and Ai136.
Generation of light-evoked action potentials (APs) was highly reliable in all effector lines except Ai168, in which optically evoked APs were observed only in a minority of cells tested (Figure S6D) . To compare the capacities of the remaining effector lines to produce optically evoked APs, we measured depolarizations in response to a 5 ms optical stimulus of increasing power ( Figure 6D ). From these, we determined the minimum power necessary to generate APs and plotted cumulative spike probability versus light intensity for the four lines ( Figure 6E ). Very low powers were required to produce APs in ChrimsonR (Ai167: 0.07-0.32 mW/mm 2 , median = 0.17 mW/mm 2 ) or ReaChR cells (Ai136: 0.06-0.27 mW/mm 2 , median = 0.11 mW/mm 2 ). Chronos and ChR2 cells required 10-to 30-fold higher powers to evoke APs (Ai90: 1.3-14.5 mW/mm 2 ; median = 3.5 mW/mm 2 ; Ai134: 0.53-3.9 mW/mm 2 ; median = 1.3 mW/mm 2 ). While the required powers are significantly larger, they are readily achievable with commonly utilized light sources, and we observed spiking in all ChR2 neurons (n = 16) and all but one Chronos neuron (n = 13; Figure S6D ). ChR2 and Chronos neurons were excited with a blue (470 nm) LED-slightly shorter than the reported excitation peak of Chronos (500 nm) (Klapoetke et al., 2014) . Use of a light source tailored to Chronos would likely provide robust spiking at even lower powers. These data correspond well with our direct recordings of opsin-mediated currents (compare Figure 6C to 6E). We next utilized light pulses of saturating intensity to determine the minimum duration of light exposure necessary to elicit APs in each effector line ( Figure S6E ). Minimum durations of exposure were below 0.5 ms in nearly all neurons tested, and Ai167 and Ai136 were the most responsive-all cells exhibited minimum duration of exposure %0.12 ms ( Figure S6F ). We also presented opsin-expressing neurons with 1 ms light pulses of saturating intensity and measured the average latency of AP firing and the jitter (standard deviation of the latency) associated with this common stimulus. All four lines displayed highly precise firing with average jitters <0.1 ms. ChrimsonR neurons (Ai167) had the lowest latency and jitter (Figures S6G and S6H) . Similar to results obtained from the Scnn1a-Tg3-Cre cross, ChrimsonR cells displayed robust and reliable spiking in response to photostimulation in layer 2/3 neurons of Cux2-CreERT2;Ai167 mice ( Figures S6F-S6H) .
Finally, we measured the fidelity of optically evoked AP firing in response to ten repeated stimuli of increasing frequency (Figures 6F and 6G) . Consistent with the slow kinetics of channel activation and deactivation, ReaChR cells (Ai136) displayed the least reliable firing in response to high-frequency stimuli. ChrimsonR (Ai167) and Chronos (Ai90) both exhibited a remarkable ability to follow optical stimuli delivered up to 50 Hz. In attempt to better differentiate the two lines, we delivered additional stimuli at (C) frequencies ranging from 60 to 100 Hz. AP fidelity was near 100% for both lines and population averages were not significantly different from each other. However, as can be appreciated from the example traces, stimulation of Ai167 neurons at very high frequencies led to AP broadening and shortening that was not seen in Ai90 ( Figure 6F ). Altogether, our analyses of photocurrents and optically evoked depolarizations across these transgenic lines suggest that they together provide a powerful and complementary toolset for a variety of optogenetic experiments.
Assessment of Adverse Effects Associated with Extremely High-Level Transgene Expression
Very high transgene expression achieved with either viral or transgenic approaches may cause unwanted phenotypes (Han et al., 2012) , and therefore, one should always be cautious and carefully evaluate cell health in each experimental context. While for the vast majority of Cre x TIGRE2.0 crosses examined (>50) the brains and labeled cells appeared healthy, we did observe some adverse effects in selected crosses ( Figure S7 ; Table  S5 ). For most of these cases, feeding the mice doxycycline-containing chow throughout the pregnancy and animal's lifetime did not ameliorate the adverse phenotypes (data not shown), suggesting that very high levels of tTA2, a potent transcriptional activator, are not well tolerated when broadly expressed in CNS, early in development and/or potentially outside of the CNS. We caution users against using Cre lines with widespread and early developmental expression and suggest using the more specific Cre lines in which we have not observed any adverse phenotypes.
We have recently reported the occurrence of aberrant cortical dynamics in some strains of GCaMP-expressing mice (Steinmetz et al., 2017) . This is an example of more subtle effects with widespread and strong calcium indicator expression, which could be alleviated by doxycycline treatment, and we have developed methods to detect them. These events resemble the synchronized interictal discharges observed in the context of epilepsy and are characterized by their repetitive discharge ($0.5 Hz), large amplitude (>10%), brief duration (<200 ms in GCaMP6f, <500 ms in GCaMP6s), and a spatial extent that includes motor and somatosensory regions of cortex. Aberrant activity was typically observed in strains with widespread expression of GCaMP across cortex, in particular when GCaMP expression was driven by Emx1-Cre, e.g., the Emx1-IRES-Cre; Camk2a-tTA;Ai93 mice. To screen for the incidence of these events in TIGRE2.0 strains, we used wide-field calcium imaging through the intact skull ( Figure 7 ; Table S6 ). We did not observe aberrant activity from GCaMP6s-expressing Slc17a7-IRES2-Cre;Ai162 mice, but we were able to detect events from GCaMP6f-expressing Slc17a7-IRES2-Cre;Ai148 mice. For comparison, we also found a low incidence of aberrant activity in Slc17a7-IRES2-Cre;Camk2a-tTA;Ai93 mice. Events resembled those from the original report (Steinmetz et al., 2017) and our consistent observations in Emx1-IRES-Cre;Camk2a-tTA;Ai93 mice (five consecutive positive observations in each of five mice, one example shown in Figure 7D ). Our analysis indicates that mice with GCaMP6s expression rarely exhibited aberrant activity, with only one available example ( Figure 7E ) indicating that our analysis is able to detect these events when reported by the slow calcium indicator.
DISCUSSION
Our previous efforts established the TIGRE locus as a new permissive docking site for insertion of exogenous promoters and transgenes (Madisen et al., 2015) . TIGRE1.0 Cre/tTAdependent intersectional reporter lines demonstrated much enhanced expression level due to tTA-mediated transcriptional amplification. Currently, the availability of tTA driver lines is limited, and in our own several attempts to create new knockin tTA (specifically, tTA2) driver lines, little to no expression was often observed, possibly due to the silencing effect at those endogenous gene loci. The CAG promoter-driven tTA2 expression in our TIGRE2.0 lines is largely resistant to silencing in nearly all the cell types we have examined, including those we failed to label using TIGRE1.0 lines, such as cortical interneurons and subcortical neuromodulatory neurons, resulting in further enhanced expression of reporter or effector genes that was never reported before. However, the labeling across some of these cell types is still not 100%, indicating that the strategy is not perfect yet and that silencing may still be an issue (Zhu et al., 2007) .
The TIGRE2.0 platform offers several major improvements over the existing genetic approaches. First, by removing one exogenous driver (tTA), the breeding strategy is simplified to a Cre-dependent approach; it also makes room for the creation of more generally useful dual recombinase-based intersectional strategies such as Cre and Dre reporters (e.g., Ai161) and Cre and Flp reporters (to be generated). Second, as discussed above, by using the robust and ubiquitous CAG promoter to drive tTA2, more consistent and uniform expression of the reporter genes across many different cell types is achieved, minimizing another type of variation. Third, the success of using two different promoters in the TIGRE locus suggests that this locus is indeed universally permissive and that it may be used for hosting other promoters or regulatory elements as well.
While the TIGRE2.0 lines represent broadly useful tools for cell-type-specific analysis, there are limitations to their utility, as with many existing genetic tools. In general, tTA is a potent transcriptional transactivator that has been reported to cause neurodegeneration when expressed at high levels (Han et al., 2012) ; thus, it is not surprising that its strong expression could be detrimental. In this regard, it is interesting to note that Pvalb-IRES-Cre;Ai163 mice had a higher proportion of Pvalb+ cells expressing GCaMP6s and also larger in vivo GCaMP6s responses than Pvalb-IRES-Cre;Ai162 mice, even though the former (containing tdTomato-P2A-tTA2) expresses tTA2 at a lower level than the latter (containing tTA2 alone). This suggests to us that future improvements can be made by moderately reducing tTA2 expression level and/or by using less potent tTA variants.
Beyond tTA2, widespread and high-level expression of other transgenes could also lead to adverse effects. For example, GCaMP6f mice are more prone to having epileptiform activities than GCaMP6s mice. For the different opsin variants, cells appeared healthier when lower-expressing ROSA26-ZtTA was used compared to Camk2a-tTA to drive Chronos, ChR2, or ReaChR from TIGRE1.0 transgenes. On the other hand, it is interesting to note that ChrimsonR appears to be well tolerated even in the TIGRE2.0 configuration and exhibits high light sensitivity and high temporal precision. Thus, every molecule likely has its own optimal range of expression and will need to be treated differently to obtain a good balance between maximizing expression or functionality and minimizing toxicity. These conclusions will likely apply to the viral approaches as well. The large set of Rosa26-, TIGRE1.0-, and TIGRE2.0-based single-copy transgenic reporter mouse lines we generated has revealed a wide range of expression levels (from insufficient in some cases to ''overkill'' in others) for a diverse set of molecular tools. They also demonstrate that we now have the ability to fine-tune transgene expression levels as needed. The lessons learned here will be as important as the positive utility demonstrated to facilitate future development and utilization of optimal genetic targeting strategies.
Our overall results suggest that the diverse set of new driver and reporter lines reported here can enable numerous celltype-specific applications. These include synaptic terminal labeling (Ai31 and Ai34); nuclear labeling (Ai75 and Ai110); in vivo visualization of anatomical structures (Chrm2-tdT); dendritic, axonal, and synaptic labeling under electron microscopy The only Emx1-IRES-Cre;Camk2a-tTA;Ai94 mouse we examined from this cross that exhibited aberrant activity (region shown is somatosensory cortex). Note the difference in event characteristics when reported by GCaMP6f (D) or GCaMP6s (E) indicator. See also Figure S7 and Tables S5 and S6. (Ai133); full neuronal morphologies (Ai139, Ai140, and Ai161); cortical and subcortical in vivo calcium imaging of cell bodies as well as processes (Ai148, Ai162, and Ai163); in vivo voltage imaging (Ai86, Ai169, and Ai170); and one-or two-photon optogenetics (Ai40, Ai80, Ai90, Ai134, Ai136, and Ai167). Combined with the large arsenal of Cre, Flp, and other driver lines already existing or being generated based on single-cell transcriptome-identified cell types, and with complementary viral vectors that allow anterograde or retrograde labeling or systemic delivery, these applications can be carried out in dense, sparse, intersectional, or connectionally labeled cell populations for very refined circuit dissection, ultimately accelerating our understanding of brain functions in healthy or diseased conditions.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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METHOD DETAILS
Transgenic mice generation All targeting vectors were constructed using gene synthesis and standard molecular cloning approaches. Knock-in driver line and Rosa26-based reporter vectors contained components that were previously described (Madisen et al., 2015; Madisen et al., 2010) . For TIGRE1.0-and 2.0-based reporters, vectors containing the following components were constructed: FRT3 -2X HS4 chicken beta globin insulators -TRE tight (1.0 lines) or TRE2 (2.0 lines) promoter -LoxP -ORF-3X stops -hGH poly(A), PGK polyA) -LoxP -gene -WPRE-bGH poly(A) -2X HS4 chicken beta globin insulators -CAG promoter -Lox2272 -ORF-3X stops -hGH poly(A), TK poly(A) -Lox2272 -tTA2 -WPRE -bGH poly(A) -Hygro-SD -FRT5. Targeting of the transgene cassettes into an endogenous gene locus or the Rosa26 locus was accomplished via standard homologous recombination using linearized targeting vector DNA or via CRISPR/Cas9-mediated genome editing using circularized targeting vector in combination with a gene-specific guide vector (Addgene plasmid #42230). Targeting of the transgene cassettes into the TIGRE locus was accomplished via Flp-recombinase mediated cassette exchange (RMCE) using circularized targeting vector and a CAG-FlpE vector (Open Biosystems) as previously described (Madisen et al., 2015) . The129S6B6F1 ES cell line, G4, was utilized directly for driver line and Rosa26-based reporter line targeting. A Flp-recombinase landing pad ES cell line derived from G4 cells that was previously described (Madisen et al., 2015) was utilized for RMCE into the TIGRE locus. Correctly targeted ES cells were identified using standard screening approaches (PCR, qPCR, and Southern blots) and injected into blastocysts to obtain chimeras and subsequent germline transmission. Resulting mice were crossed to the Rosa26-PhiC31 mice (JAX Stock # 007743) to delete the pPGK-neo or pPGK-hygro selection marker cassette, and then backcrossed to C57BL/6J mice and maintained in C57BL/6J congenic background. TIGRE2.0 reporter lines Ai139, Ai140 and Ai148 have been bred to homozygosity and are maintained in this state without any notable issues. Only mice heterozygous for both reporter and driver transgenes were used for experiments.
Administration of trimethoprim or tamoxifen
Induction of DHFR-domain containing dCre, dgCre or dgFlpO driver lines was done by administration via oral gavage (PO) of trimethoprim (TMP) at 0.3 mg/g body weight per day for 3 days in an adult mouse. TMP working solution was diluted from a 10x stock in 100% DMSO with a 2% methylcellulose solution. The GFP part present in dgCre and dgFlpO lines exhibits no visible fluorescence with or without TMP induction. Induction of CreERT2 driver lines was done by administration via oral gavage (PO) of tamoxifen (50 mg/ml in corn oil) at 0.2 mg/g body weight per day for 1-5 days in an adult mouse, or 1 day in a mouse younger than P28. Mice can be used for experiments starting at 1-2 weeks after TMP or tamoxifen dosing.
In situ hybridization All in situ hybridization (ISH) was performed via a standardized production platform that was previously described (Harris et al., 2014; Madisen et al., 2010) . Data can be found in the AIBS Transgenic Characterization database (http://connectivity.brain-map.org/ transgenic/search/basic). Brain region acronyms: ARH, arcuate hypothalamic nucleus. CEA, central amygdalar nucleus. CLA, claustrum. CP, caudoputamen. CTX, cortex. DR, dorsal nucleus raphe. ENTl, entorhinal area, lateral part. ENTm, entorhinal area, medial part. EW, EdingerWestphal nucleus. HPF, hippocampal formation. LC, locus ceruleus.
LGd, dorsal part of the lateral geniculate complex.
LGv, ventral part of the lateral geniculate complex. MEA, medial amygdalar nucleus. SI, substantia innominate. SNc, substantia nigra, compact part. TH, thalamus. VMH, ventromedial hypothalamic nucleus. VPM, ventral posteromedial nucleus of the thalamus.
Immunohistochemistry and imaging
Mice were transcardially perfused with 0.1M phosphate buffered saline (PBS) followed by 4% paraformaldehyde (PFA). Brains were removed, post-fixed in PFA overnight, followed by an additional incubation overnight in 30% sucrose. Coronal or sagittal sections (50 mm) were cut using a freezing microtome and sections were stored in PBS until use. For parvalbumin or 2A antibody staining, free floating brain sections were rinsed three times in phosphate-buffered saline (PBS), blocked for 1 hour in PBS containing 5% donor donkey serum, 2% bovine serum albumin (BSA) and 0.1% Triton X-100, and incubated overnight at 4 C in the anti-parvalbumin primary antibody (PV, 1:3000, Swant PV235) or in the anti-2A peptide primary antibody (2A, 1:500, Millipore ABS31). The following day, sections were washed three times in PBS, followed by incubation in blocking solution containing an Alexa 647 conjugated secondary antibody (1:250, Jackson 715-605-151), washed in PBS, and mounted in Vectashield containing DAPI (H-1500, Vector Labs) . For all other antibody staining, sections were subjected to antigen retrieval with 10 mM sodium citrate pH 6.0 with 0.05% Triton X-100 (heated to 75 C for 20 minutes), rinsed, and then blocked with 5% normal donkey serum and 0.2% Triton X-100 in PBS for one hour. Tissue was then incubated in primary antibodies diluted in the blocking solution for 48-72 hours at 4 C, washed the following day in 0.2% Triton X-100 in PBS and then incubated in the appropriate Alexa-conjugated secondary antibodies (1:500, ThermoFisher). Sections were then rinsed in 0.2% Triton X-100 in PBS, followed by PBS alone, mounted on gelatin-coated slides and coverslipped with prolong diamond antifade mounting media (P36965, ThermoFisher). The following primary antibodies were used to detect transgene expression in neuromodulatory cell types: anti-norepinephrine transporter (NET, 1:500, Atlas Antibodies AMAb91116), anti-tyrosine hydroxylase (TH, 1:1000, Abcam ab112), anti-serotonin transporter (SERT, 1:500, EMDMillipore MAB1564), anti-tryptophan hydroxylase 2 (TPH2, 1:250, EMDMillipore ABN60), anti-choline acetyltransferase (ChAT, 1:300, EMDMillipore AB144P). In a subset of experiments, we compared antibody-enhancement to native GCaMP6 fluorescence using an anti-GFP primary antibody (1:5000, Abcam, Ab13970) and donkey anti-chicken secondary antibody (703-545-155, Jackson ImmunoResearch). Images (1024 X 1024) of native or antibody-enhanced fluorescence were collected on a TissueCyte 1000 (Tissue Vision), an Olympus Fluoview FV1000 confocal microscope or a Leica SP8 resonant-scanning confocal microscope and were manually counted for each experimental condition using the cell counter plugin within ImageJ (K. De Vos, University of Sheffield) by observers blind to the genotype of the animals.
Electron Microscopy
Mice were transcardially perfused with a fixative mixture of 2.5% paraformaldehyde and 1.25% glutaraldehyde. After dissection, coronal slices were cut with a vibratome and post-fixed for 12 -48 h. To visualize APEX2, slices were incubated in a solution of 3,3 0 -diaminobenzidine (0.3 mg/mL, or 1.4 mM), 2.5 mM ammonium nickel sulfate, in 0.1 M phosphate buffer. Following incubation, hydrogen peroxide was added to a final concentration of 1 mM and the DAB reaction was monitored under a dissecting microscope. After sufficient reaction time, sections were extensively washed and prepared for reduced osmium treatment (rOTO). Ferricyanide was used to reduce Osmium and Thiocarbohydrazide (TCH) for further intensification of the staining. Uranyl acetate and lead aspartate were used to enhance contrast. After resin embedding, ultrathin sections (40 nm) were cut in a Leica ultra-microtome and imaged with Transmission electron microscopy in a JEOL 1200 EX II.
Single-cell RNA-sequencing For comparison of reporter transgene expression level, we injected AAV2/1-pCAG-FLEX-EGFP-WPRE-pA (Oh et al., 2014) into VISp of two male Snap25-IRES2-Cre mice at P25 and P44 respectively. Stereotaxic injection procedures were performed as previous described (Oh et al., 2014) . The mouse injected at P25 was allowed to survive for 32 days post injection, and cells were collected when the mouse was P57. The mouse injected at P44 was allowed to survive for 21 days post injection, and cells were collected when the mouse was P65. We collected GFP-positive cells from L1-3, L4, L5, and L6 at the injection site.
Cells from transgenic mice or transgenic mice injected with AAV-pCAG-FLEX-EGFP-WPRE-pA were collected by microdissection, single-cell suspension, and single-cell FACS. All cells were FACS-isolated with selection for one of the fluorescent proteins: green fluorescence for Pvalb-T2A-CreERT2;Ai139, Pvalb-IRES-Cre;Ai162, Pvalb-IRES-Cre;Ai163, Sst-IRESCre;Ai14;Ai148, and Scnn1a-Tg3-Cre;Ai139; red fluorescence for Pvalb-IRES-Cre;Ai14, Sst-IRES-Cre;Ai14, Rbp4-Cre_KL100;Ai14, Rbp4-Cre_KL100;Ai14;Ai148, Scnn1a-Tg3-Cre;Ai14 and Snap25-IRES2-Cre;Ai14 cells.
Cells were then frozen at À80 C, and were later processed for scRNA-seq using the SMART-Seq v4 method, as described in the Allen Institute Transcriptomics Technical Whitepaper (http://help.brain-map.org/download/attachments/8323525/ CellTypes_Transcriptomics_Overview.pdf) (Tasic et al., 2016) . After sequencing, raw data was quantified using STAR v2.5.3 and were aligned to both a Ref-Seq transcriptome index for the mm10 genome, and a custom index consisting of transgene sequences. FPKM values were calculated by dividing raw counts for each transgene by the length of each gene in kilobases and by the total number of reads that mapped to both the transcripome index and to the transgene sequences in millions of reads.
To examine transcriptome-wide gene expression changes, scRNA-seq datasets were mapped to reference transcriptomic cell types using nearest centroid classifiers. Differentially expressed genes between groups of cells were detected using limma voom mode (Ritchie et al., 2015) .
In vivo two-photon calcium imaging in cortical interneurons
Detailed surgical and imaging procedures have been published previously (Madisen et al., 2015) . Briefly, adult mice (2-5 months old, both genders, n = 13, including 2 Sst-IRES-Cre;Ai14;Ai95, 2 Sst-IRES-Cre;Ai14;Ai148, 3 Pvalb-IRES-Cre; Ai163, 1 Pvalb-IRES-Cre; Ai162, 2 Pvalb-IRES-Cre;Ai14;Ai148 and 3 Vip-IRES-Cre;Ai14;Ai148 mice) were implanted with a metal head-post and a 3-5-mm cranial window over the left visual cortical area under anesthesia. After 7 days of recovery from surgery, mice were habituated to head fixation and presentation of visual stimulations on an in-house made running device (a freely-rotating running disc) for 2 weeks before imaging experiment started. During imaging, mice were awake, head-fixed but allowed to run or rest on the freely-rotating running disc with or without visual stimuli presented on a calibrated LCD monitor spanning 60 in elevation and 130 in azimuth to the contralateral (right) eye. For visually evoked responses, whole-screen sinusoidal drifting gratings were presented showing 8 orientations (0 to 315 in 45 increment), 3 or 4 spatial frequencies (SFs, [0.02, 0.04, 0.08] or [0.02, 0.04, 0.08 and 0.16] cycle per degree) and 1 temporal frequency (2 Hz), presented at 80% contrast in a random sequence for 8 repetitions. Each drifting grating lasted for 2 s with an interstimulus-interval of 1 or 2 s. A gray screen at mean illuminance was presented randomly for 16 times. The mouse's eye was positioned $22 cm away from the center of the monitor. Due to the choice of whole-screen visual stimuli, we did not track the eye position.
Two-photon calcium imaging was performed using a Bruker (Prairie) two-photon microscope with 8 kHz resonant scanners, coupled with a Chameleon Ultra II Ti:sapphire laser system (Coherent). In the current study, we crossed the Ai148 reporter lines with Pvalb-, Sst-and Vip-IRES-Cre;Ai14 mice to co-express the GECI GCaMP6f together with a red, calcium insensitive cytosol marker tdTomato in PV, SST and VIP positive inhibitory interneurons, respectively. Co-expression of tdTomato facilitated locating and calcium imaging those interneurons with low expression of GECI. Fluorescence excited at 920 nm wavelength with < 70 mW laser power measured after objective was collected in two spectral channels using green (510/42 nm) and red (641/75 nm) emission filters. The emission filter set we selected ensured good separation between red and green channels. Fluorescence images were acquired at various frame rates (512X512 pixels, 30 Hz; 256X256 pixels, 60 Hz) through a 16x water-immersion objective lens (Nikon, NA 0.8), with or without visual stimulations.
In vivo two-photon calcium imaging in cortical excitatory neurons Imaging of the Ai93 and Ai148 reporter lines crossed with Ntsr1-Cre_GN220 and Tlx3-Cre_PL56, which express GCaMP6f in deep cortical layer 6 and 5 respectively, was conducted in the Allen Brain Observatory pipeline. Briefly, adult mice (from P37 to P63, both sexes, n = 7) were implanted with a metal head-post and a $5-mm cranial window over the left visual cortical area under anesthesia. After 7 days of recovery from surgery, the visual cortex was mapped using intrinsic imaging. An automated segmentation and annotation module was developed to delineate boundaries between visual areas. To provide a reliable targeting of two-photon calcium imaging experiments, a consistent anatomical coordinate corresponding to the center of V1 (which maps to center of the retina) was used.
Mice were then habituated to head fixation and presentation of visual stimulations on an in-house made running device (a freelyrotating running disc) for 2 weeks before imaging experiment started. During imaging, mice were awake, head-fixed but allowed to run or rest on the freely-rotating running disc with or without visual stimuli presented on a calibrated LCD monitor.
The screen spanned 120 X 95 of visual space and was positioned 15 cm from the mouse (118.6 mm lateral, 86.2 mm anterior and 31.6 mm dorsal to the right eye). Each screen (ASUS PA248Q LCD monitor) was gamma calibrated using a USB-650 Red Tide Spectrometer (Ocean Optics). Luminance was measured using a SpectroCAL MKII Spectro radiometer (Cambridge Research Systems). Monitors brightness (30%) and contrast (50%) corresponded to a mean luminance of 50 cd/m2.
For quantifying grating responses, the stimulus consisted of a full field drifting sinusoidal grating at a single spatial frequency (0.04 cycles/degree) and contrast (80%). The grating was presented at 8 different directions (separated by 45
) and at 5 temporal frequencies (1, 2, 4, 8, 15 Hz) . Each grating was presented for 2 s, followed by 1 s of mean luminance gray before the next grating. Each grating condition (direction & temporal frequency combination) was presented 15 times, in a random order. There were blank sweeps (i.e., mean luminance gray instead of grating) presented approximately once every 20 gratings.
Two-photon calcium imaging was performed using a Nikon A1R MP+. The Nikon system was adapted to provide space to accommodate the behavior apparatus. Laser excitation was provided by a Ti:Sapphire laser (Chameleon Vision -Coherent) at 910 nm. Pre-compensation was set at $10,000 fs2. Movies were recorded at 30Hz using resonant scanners over a 400-mm field of view. Two-photon movies (512x512 pixels, 30Hz), eye tracking (30Hz), and behavior (30Hz) were recorded and continuously monitored. We imaged the deep cortical layers (layer 5 and 6) through a 16x water-immersion objective lens (Nikon, NA 0.8) using less than 240 mW (measured after objective) to avoid brain damage.
Acute slice physiology and optogenetics Para-sagittal slices were prepared from 6-16 weeks old mice of either sex. Mice were anaesthetized with isoflurane, decapitated and brains were swiftly removed. 350 mm slices were cut using a Leica VT1200S vibratome in ice cold slicing solution. Slicing solution contained 87 mM NMDG, 2.5 mM KCl, 1.2 mM NaH 2 PO 4 , 30 mM NaHCO 3 , 20 mM HEPES, 25 mM glucose, 12 mM N-acetyl cysteine, 5 mM Na-ascorbate, 2 mM thiourea, 3 mM Na-pyruvate, 10 mM MgSO 4 , 0.5 mM CaCl 2 . pH was adjusted to 7.3-7.4 using HCl. Slices were stored in slicing solution for 15 minutes at 34 C, after which they were transferred to artificial cerebrospinal fluid (ACSF) and stored at room temperature until use. ACSF contained 124 mM NaCl, 2.5 mM KCl, 1.2 mM NaH 2 PO 4 , 24 mM NaHCO 3 , 5 mM HEPES, 12.5 mM glucose, 2 mM MgSO 4 and 2 mM CaCl 2 . pH was adjusted to 7.3-7.4 mM using NaOH, osmolarity = 290-300 mOsm. Prior to use, slices were transferred to a recording chamber continuously perfused with ACSF heated to 32 ± 2 C. Recordings were made using 3 -5 MU borosilicate glass pipettes. Internal solution contained 130 mM K-gluconate, 4 mM KCl, 10 mM HEPES, 0.3 mM EGTA, 10 mM phosphocreatine disodium salt, 4 mM MgATP and 0.3 mM Na-GTP. During recording, 10 mM NBQX was added to ACSF to block excitatory synaptic transmission. Measurements of photocurrents were performed with neurons clamped to À70 mV. 100 nM tetrodotoxin was added to the bath to block voltage-gated sodium channels in voltage clamp recordings. Access resistance was < 20 MU at the start of all experiments and was monitored throughout the experiment. Recordings were terminated if access resistance increased to > 25 MU. Data were recorded using Multiclamp 700B amplifiers (Axon Instruments) and digitized using ITC-18 data acquisition interfaces (Heka). Data were acquired using custom scripts in Igor Pro (Wavemetrics).
Photostimulation of cells was performed using either a 470 nm or 590 nm LED reflected into a 63x/1.0 NA water immersion objective. The power of the light stimulus was controlled via pulse-width modulation of TTL signals passed to an analog LED driver (LightSpeed Technologies). Powers were measured using a power meter (Thor Labs PM-100A) placed after the objective. Experiments measuring action potential (AP) entrainment at different frequencies utilized different pulse widths for each transgenic line. This was to accommodate the differences in minimum light duration necessary to evoke a single AP ( Figure S6F ). Pulse durations utilized were Ai90: 1 ms; Ai134: 0.5 ms, Ai136: 0.05 ms, and Ai167: 0.2 ms. Experiments performed using longer pulses in Ai136 and Ai167 mice generally resulted in multiple APs in response to the first pulse, followed by decreased fidelity at the end of the pulse train.
Wide-field calcium imaging
Wide-field calcium imaging was performed either through the intact skull or through a 5-mm-diameter chronically implanted cranial window centered over the left visual cortex. For through-skull imaging, the skull was exposed and cleared of periosteum, and a #1.5 borosilicate coverslip (Electron Microscopy Sciences, #72204-01) was fixed to the skull surface by a layer of clear cement (C&B Metabond, Sun Medical Co.). A 3D-printed light shield was fixed around the coverslip using additional Metabond, and the outward-facing surfaces were coated with an opaque resin (Lang Dental Jetliquid, MediMark). Mice with chronically implanted windows received a 5-mm-diameter craniotomy over the left hemisphere, centered at 2.7 mm lateral and 1.3 mm anterior to lambda. The craniotomy was sealed with a stack of three #1 coverslips, attached to each other using optical adhesive (Norland) and to the skull with Metabond. The window provided optical access to the left visual cortex, the posterior aspect of somatosensory cortex and medial aspect of dorsal retrosplenial cortex. In both cases, a custom-manufactured titanium headpost was fixed posterior to the lightshield/coverslip and dorsal to the cerebellum using Metabond. All surgical procedures were performed under isoflurane anesthesia. Image acquisition used a Hamamatsu Flash4.0 v2 or v3 sCMOS camera running with a 10-ms rolling exposure (100 Hz). Images were produced by a tandem-lens macroscope (Scimedia THT-FLSP) with 1.0x tube and objective lenses (Leica 10450028) for through skull imaging or a 1.0x tube lens paired to a 1.6x objective lens (Leica 10450029) for imaging through the chronically implanted window. Epifluorescence illumination used a 470-nm LED (Thorlabs M470L3) filtered (Semrock FF01-474/27-50) and reflected by a dichroic mirror (Semrock FF495-Di03-50 x70) through the objective lens. Fluorescence emission passed through a filter (Semrock FF01-525/45-50) to the camera. At all locations, mice were either male or female and were 7-30 weeks of age.
QUANTIFICATION AND STATISTICAL ANALYSIS
Transgene expression data were analyzed and graphed using GraphPad Prism 7.02 software (Hearne Scientific Software, Chicago, IL). Data presented are mean ± standard error from the mean.
In vivo two-photon calcium imaging data collected from cortical interneurons were analyzed with in-house developed MATLAB scripts. In summary, data were corrected for in-plane motion artifacts using cross-correlation motion correction method between frames. Image segmentation was done using Independent Component Analysis (ICA) followed by automated Region of Interest (ROI) selection with manual confirmation/correction. Green fluorescence signal of all pixels within each ROI was averaged by image frames. Fluorescence signal from the red channel was not quantitatively analyzed. No neuropil signal subtraction was done for these data. The baseline for DF/F calculation was determined from the mean fluorescence within a 0.5 s window prior to visual stimulus onset.
In vivo two photon calcium imaging data collected from cortical excitatory neurons were analyzed with in-house developed scripts. A comprehensive description of the data analysis pipeline is available on the Allen Brain Observatory portal (http://help.brain-map. org/display/observatory/Documentation). Briefly, each pixel of the calcium movie was first corrected for pixel leakage, then each frame was motion corrected to a reference frame. A rule-based segmentation algorithm automatically extracted all ROIs covering active somatic compartments. For each ROI, neuropil signals were then subtracted and nearby ROIs were unmixed. Each ROI associated trace was then converted to DF/F. For drifting grating quantification, tuning was calculated from the averaged response over the duration of stimulus presentation.
Analysis of acute physiology and optogenetics data was performed using Igor Pro and custom Python (2.7) scripts combined with the Allen Institute Software Development Kit to measure the timing of APs in whole cell recordings. Statistical comparisons of population averages of transgenic lines were made by first performing a one-way ANOVA, followed by unpaired t tests between groups with a Bonferroni correction for multiple comparisons (either 6 comparisons between 4 groups, a = 0.0083; or 10 comparisons between 5 groups, a = 0.005). Throughout the study, sample number n = number of cells recorded.
Wide-field calcium imaging data were spatially downsampled by averaging, and calcium traces were obtained by subtracting and then dividing each pixel by its mean over the entire time series. Traces were analyzed by finding peaks and computing two parameters: prominence and full-width at half-prominence. Prominence is defined as the height of the peak relative to the greater of the two minima between the peak and its surrounding two higher peaks (or beginning/end of trace if no higher peak). Peak detection used PeakUtils 1.0.3 (Python 2.7).
DATA AND SOFTWARE AVAILABILITY
The accession number for the single-cell RNA-sequencing data reported in this paper is GEO: GSE112846. RT, reticular nucleus of the thalamus. SCH, suprachiasmatic nucleus. SI, substantia innominata. SNr, substantia nigra, reticular part. In general, we also noted the presence of Cre-independent, low-level GFP fluorescence which was most pronounced in hippocampal excitatory neurons, likely due to the leaky expression from the TRE2 promoter (data not shown), but this should have minimal effect to most applications of these new tools. (B) We generated a Cre and Dre-dependent GFP-expressing intersectional TIGRE2.0 reporter line: Ai161(TIT2L-GFP-ICR-tTA2) ('R' stands for RoxStop2Rox), in which tTA2 is under Dre control. This line expresses GFP in a Cre-and Dre-dependent manner. Shown here is high-level expression of GFP (imaged by the TissueCyte system) in different neuronal populations defined by two intersectional crosses. In Sst-IRES-Cre;Pvalb-T2A-Dre;Ai161 mice, GFP labels Sst+/Pvalb+ interneurons, whereas in Sim1-Cre_KJ18;Pvalb-T2A-Dre;Ai161 mice, GFP labels Pvalb+ subcortical-projecting layer 5 excitatory neurons. In addition, due to the low-level promiscuous recombination activity of Cre on the Rox sites, in various Cre x Ai161 double transgenic mice, GFP reporter was detected in a small number of cells. This promiscuous recombination occurred more frequently in subcortical areas (data not shown). Additional notes regarding other attempts to co-express tTA and reporter gene in the TIGRE locus prior to the development of TIGRE2.0 strategy. We first tried two approaches to co-express tTA and a GFP reporter gene, both under Cre control, via a 2A sequence or a bidirectional Bi-Tet promoter, with the hope that upon Cre-mediated recombination, a background level of tTA expression from the TRE or Bi-Tet promoter would initiate a self-amplifying cascade of expression of both tTA and the reporter gene. However, upon Cre transfection of targeted ES clones, we observed no GFP expression (data not shown). Since the TRE promoter we had used was the TRE-Tight version, we then replaced it with the original, 'leakier' tetO promoter (TRE2). In targeted ES clones for both 2A and Bi-Tet versions, we did observe GFP positive cells upon Cre transfection, however, the proportion of green cells was low (data not shown). We went ahead and generated a mouse line from the TRE2-LSL-GFP-2A-tTA2 clone (named Ai109). However, upon crossing Ai109 to 3 Cre lines, Pvalb-IRES-Cre, Nr5a1-Cre and Sst-IRES-Cre, we observed very few GFP-expressing cells in some but not all regions where Cre recombination would normally occur (data not shown). Thus we did not pursue this approach further.
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Slc6a4-CreERT2_EZ13; Ai148
Chat-IRES-Cre; Ai148
Slc6a3-IRES-Cre; Ai148
Dbh-Cre_KH212; Ai148 In addition to mouse strains described in Figure 6 , also examined are Cux2-CreERT2;Ai167 and Cux2-CreERT;Ai168 expressing ChrimsonR and oChIEF, respectively, in cortical layer 2/3 excitatory neurons. We also examined Pvalb-IRES-Cre;Ai168 mice expressing oChIEF in Pvalb+ interneurons. For all data presented here, neurons recorded from Ai90, Ai134 and Ai168 animals were stimulated with 470 nm light, whereas experiments characterizing Ai136 and Ai167 mice used 590 nm light. (A) Time constants of activation measured by a mono-exponential fit from the onset of the light pulse to the peak of the photocurrent (see Figure 6A ). Ai90: 0.81 ± 0.21 ms; Ai134: 2.3 ± 0.3 ms; Ai136: 13.1 ± 1.5 ms; Ai167: 2.0 ± 0.2 ms; Ai168 3.3 ± 0.8 ms. p < 0.001 for all comparisons except: Ai134 versus Ai167; Ai134 versus Ai168 and Ai167 versus Ai168. (B) Time constants of de-activation measured by a mono-exponential fit from the termination of the light pulse to the return of the current to baseline (see Figure 6A ). Ai90: 3.8 ± 0.4 ms; Ai134: 13.7 ± 2.5 ms; Ai136: 478 ± 166 ms; Ai167: 17.6 ± 2.2 ms; Ai168: 6.6 ± 1.1 ms. p < 0.0005 for all comparisons. (C) Peak/steady-state ratio. Steady-state was measured as the average current amplitude during the final 5 ms of the 100 ms light exposure (see Figure 6A ). Ai90: 2.66 ± 0.39; Ai134: 1.72 ± 0.04; Ai136: 1.01 ± 0.003; Ai167: 1.10 ± 0.03; Ai168 1.14 ± 0.08 (n = 6-10 cells for each group in panels A-C). p < 0.005 for all comparisons except: Ai136 versus Ai168 and Ai167 versus Ai168. (D) Percentage of cells in each transgenic line displaying action potential (AP) firing, subthreshold response or no response to optical stimulation. We first tested the ability of each neuron to generate light-evoked APs with 1 ms light pulses. If AP firing was not observed, light exposure was prolonged (up to 50 ms) to further
